Literature DB >> 35835129

Reforms to accelerated approval of new medicines: long overdue.

Thomas J Hwang1, Quoc-Dien Trinh2, Ariadna Tibau3, Kerstin N Vokinger4.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35835129     DOI： 10.1016/S0140-6736(22)01276-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   202.731


× No keyword cloud information.
  1 in total

1.  Therapeutic Value of Drugs Granted Accelerated Approval or Conditional Marketing Authorization in the US and Europe From 2007 to 2021.

Authors:  Kerstin N Vokinger; Aaron S Kesselheim; Camille E G Glaus; Thomas J Hwang
Journal:  JAMA Health Forum       Date:  2022-08-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.